Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron versus metoclopramide for nausea and vomiting in the emergency department
ACTRN12609000733279Phase 3Completed
- Sponsor
- Austin Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tropisetron and metoclopramide in Nausea and Vomiting (2 arms), sponsored by Austin Hospital. Primary endpoints: Nausea score on visual analogue scale at 240 minutes and Incidence of vomiting at 240 minutes. Started Oct 2009; status: completed.
02
Drugs
tropisetronmetoclopramide
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on ACTRN12609000733279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000733279.